Friedreich Ataxia
Rare Disease·MeSH: Friedreich Ataxia
Prevalence
5.0 / 100K
9 drugs in development·5 companies·11 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Omaveloxolone | BIOGEN INC. (BIIB) |
Phase 2(5)
Compare drugs
Frequently asked questions
How many drugs are in development for Friedreich Ataxia?
BioSniper tracks 9 drugs in development for Friedreich Ataxia across 5 companies.
How many clinical trials target Friedreich Ataxia?
There are 11 clinical trials targeting Friedreich Ataxia tracked by BioSniper.
What is the prevalence of Friedreich Ataxia?
The estimated prevalence of Friedreich Ataxia is approximately 5.0 per 100,000 population.
Deep-dive into Friedreich Ataxia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis